Investorstemcell - investorstemcell.com - Investor Stemcell
General Information:
Latest News:
Opexa Announces Issuance of 50th Patent for T-cell Immunotherapy Platform 27 Aug 2013 | 06:11 pm
08/27 09:00 AM THE WOODLANDS, Texas–(BUSINESS WIRE)– Opexa Therapeutics, Inc. (OPXA:$1.47,00$0.06,004.26%) , a biotechnology company developing Tcelna®, a novel T-cell immunotherapy for the treatment...
InVivo Therapeutics Updates Clinical Plan 27 Aug 2013 | 06:10 pm
CAMBRIDGE, Mass.–(BUSINESS WIRE)– InVivo Therapeutics Holdings Corp. (NVIV:$3.45,00$0.47,0015.77%) , a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and othe...
Cardium’s LifeAgain Announces Commercialization Agreement With AgencyONE 26 Aug 2013 | 06:23 pm
Cardium’s LifeAgain Announces Commercialization Agreement With AgencyONE Based On Advanced Medical Data Analytics Platform Technology Pioneering New and Innovative Life Insurance for Men with Active ...
Okyanos Heart Institute Inks Deal With International Med-X and Philips Healthcare 26 Aug 2013 | 06:21 pm
Okyanos Heart Institute Inks Deal With International Med-X and Philips Healthcare For Cardiac Cath Lab Equipment To Treat Heart Disease Patients With Adult Stem Cell Therapy Freeport, The Bahamas Rec...
Cancer scientists discover novel way gene controls stem cell self-renewal 26 Aug 2013 | 06:16 pm
Contact: Jane Finlayson jane.finlayson@uhn.ca 416-946-2846 University Health Network (TORONTO, Canada – Aug. 25, 2013) – Stem cell scientists at the Princess Margaret Cancer Centre have discovered...
NeoStem Welcomes Robert Dickey IV as Its New Chief Financial Officer 19 Aug 2013 | 06:09 pm
08/19 07:30 AM NEW YORK, Aug. 19, 2013 (GLOBE NEWSWIRE) — NeoStem, Inc. (NBS:$7.11,00$-0.05,00-0.70%) (“NeoStem” or the “Company”), a leader in the emerging cellular therapy market, announced today t...
BioTime CEO Dr. Michael West to Give Keynote 19 Aug 2013 | 06:04 pm
BioTime CEO Dr. Michael West to Give Keynote Address at the MSC 2013 Adult Stem Cell Therapy & Regenerative Medicine Conference 08/19 09:00 AM ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (BTX:$3.6...
Grafix® Demonstrates Overwhelming Efficacy in Landmark Stem Cell Study for the Treatment of Diabetic Foot Ulcers 13 Aug 2013 | 05:40 pm
Grafix® Demonstrates Overwhelming Efficacy in Landmark Stem Cell Study for the Treatment of Diabetic Foot Ulcers Grafix closes three times as many wounds as standard of care – the largest relative im...
NeoStem to Present at Two Conferences in August 13 Aug 2013 | 05:24 pm
08/13 07:30 AM NEW YORK, Aug. 13, 2013 (GLOBE NEWSWIRE) — NeoStem, Inc. (NBS:$6.92,00$0.02,000.29%) (“NeoStem” or the “Company”), a leader in the emerging cellular therapy market, announced today tha...
BioLife Solutions Expands Strategic Relationship with STEMCELL Technologies Inc. 13 Aug 2013 | 05:09 pm
CryoStor® cGMP Serum-Free, Protein-Free Freeze Media Used in Launch of More than 50 New Frozen Cell Products 08/13 06:00 AM BOTHELL, Wash., Aug. 13, 2013 /PRNewswire/ — BioLife Solutions, Inc. (OTCQB...
